• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SIEMENS HEALTHCARE DIAGNOSTICS, INC. ATELLICA IM SARS-COV-2 TOTAL (COV2T); SARS-COV-2 TOTAL IMMUNOASSAY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SIEMENS HEALTHCARE DIAGNOSTICS, INC. ATELLICA IM SARS-COV-2 TOTAL (COV2T); SARS-COV-2 TOTAL IMMUNOASSAY Back to Search Results
Model Number N/A
Device Problem False Positive Result (1227)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 02/18/2022
Event Type  malfunction  
Manufacturer Narrative
An outside of the united states (ous) customer contacted the siemens customer care center (ccc) to report an atellica im sars-cov-2 total (cov2t) reactive (positive) result was obtained from one sample and the result was considered discordant compared to testing with an alternate method.The sample was also reactive with a different lot of atellica im sars-cov-2 total.Qc was in range at the time of testing.The interpretation of results section of the instructions for use (ifu) states: "the system reports advia centaur cov2t assay results in index values or u/ml and as non-reactive or reactive: non-reactive: < 1.00 index (u/ml).These samples are considered negative for sars-cov-2 antibodies.Reactive:
 
Event Description
The customer reported an atellica im sars-cov-2 total (cov2t) reactive (positive) result was obtained from one sample and the result was considered discordant compared to testing with an alternate method.The sample was also reactive with a different lot of atellica im sars-cov-2 total.It is unknown if the reactive result was reported to the physician(s).There are no reports that treatment was altered or prescribed or adverse health consequences due to the discordant, reactive atellica im sars-cov-2 total (cov2t) result.
 
Manufacturer Narrative
Siemens filed the initial mdr 1219913-2022-00089 on march 18, 2022.March 24, 2022, additional information: an outside of the united states (ous) customer contacted the siemens customer care center (ccc) to report an atellica im sars-cov-2 total (cov2t) reactive (positive) result was obtained from one sample and the result was considered discordant compared to testing with an alternate method.The sample was also reactive with a different lot of atellica im sars-cov-2 total.Siemens healthcare diagnostics has completed the investigation into alleged difference in the cov2t result between atellica im sars-cov-2 total (cov2t) and an alternative method.Quality control and calibrations were appropriate at the time of testing.No patient history was available.This appears to be a sample-specific issue however without further medical history siemens healthcare is unable to determine root cause.No product nonconformance was identified.In section h6, the investigation finding, and investigation conclusion codes were updated.Mdr 1219913-2022-00088 supplemental 1 and mdr 1219913-2022-00089 supplemental 1 were filed for the same event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ATELLICA IM SARS-COV-2 TOTAL (COV2T)
Type of Device
SARS-COV-2 TOTAL IMMUNOASSAY
Manufacturer (Section D)
SIEMENS HEALTHCARE DIAGNOSTICS, INC.
511 benedict avenue
tarrytown NY 10591 5097
Manufacturer (Section G)
SIEMENS HEALTHCARE DIAGNOSTICS, INC
333 coney street
east walpole MA 02032
Manufacturer Contact
barry memishian
333 coney street
east walpole, MA 02032
5082985306
MDR Report Key13831097
MDR Text Key297575240
Report Number1219913-2022-00089
Device Sequence Number1
Product Code QKO
Combination Product (y/n)N
Reporter Country CodeAS
PMA/PMN Number
EUA201367
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 04/21/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/20/2022
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date08/15/2022
Device Model NumberN/A
Device Catalogue Number11206711
Device Lot Number013
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/24/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured01/19/2022
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-